OREX

Orexigen Therapeutics, Inc. News Headlines

$4.97
*  
0.02
0.4%
Get OREX Alerts
*Delayed - data as of Aug. 1, 2014  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Possible Delay In Orexigen Approval Process In Europe
7/31/2014 9:54:00 AM - Seeking Alpha

Arena Conference Call Sets Stage For Near Term Equity Movement
7/28/2014 2:07:00 PM - Seeking Alpha

Orexigen Therapeutics, Inc. (OREX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7/16/2014 8:00:00 AM - Zacks.com

Arena Stock Holds On Expected Dip In Sales - Bottom May Be In
7/11/2014 1:01:00 PM - Seeking Alpha

Close Calls: Heluva Week
6/20/2014 5:11:00 PM - Market Intelligence Center

The Anti-Obesity Space Is Not As Simple As Some Think
6/20/2014 11:34:00 AM - Seeking Alpha

Orexigen Therapeutics To Present At Wells Fargo Conference; Webcast At 1:50 PM
6/18/2014 12:50:00 PM - RTT News

Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar - Analyst Blog
6/18/2014 10:33:00 AM - Zacks.com

Orexigen (OREX) in Focus: Stock Moves 7.5% Higher - Tale of the Tape
6/17/2014 9:46:00 AM - Zacks.com

What Will It Take For Arena Stock To Rise?
6/16/2014 4:19:00 PM - Seeking Alpha

Vivus Suit Preserves Exclusivity Of Qsymia - For Now
6/13/2014 2:56:00 PM - Seeking Alpha

Arena's Belviq Sales Do More Than Recover
6/13/2014 2:49:00 PM - Seeking Alpha

Orexigen Slumps as Obesity Drug Approval Delayed - Analyst Blog
6/12/2014 6:28:00 PM - Zacks.com

Orexigen Therapeutics (OREX) in Focus: Stock Tumbles 14.7% - Tale of the Tape
6/12/2014 8:56:00 AM - Zacks.com

Cramer's Lightning Round - Trains Are On The Rails (6/11/14)
6/12/2014 4:47:00 AM - Seeking Alpha

Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; Orexigen Still Down 15%
6/11/2014 3:48:14 PM - Benzinga

Mid-Day Market Update: ULTA Salon Rises After Strong Results; Orexigen Shares Slide
6/11/2014 12:34:06 PM - Benzinga

Biotech Stock Roundup: Biogen Hemophilia Drug Approved, Ariad & Halozyme Clinical Hold Lifted - Analyst Blog
6/11/2014 12:16:00 PM - Zacks.com

Orexigen (OREX) Enters Overbought Territory - Tale of the Tape
6/11/2014 10:23:04 AM - Zacks.com

Mid-Morning Market Update: Markets Drop; H&R Block Posts Higher Profit
6/11/2014 10:13:50 AM - Benzinga

FDA Delays Decision On Orexigen Anti-Obesity Drug - What This Means To The Stock
6/11/2014 9:28:00 AM - Seeking Alpha

Futures Drift Lower As Lower Global Growth Forecasts, Cautious Investors Weigh on Equities
6/11/2014 9:17:31 AM - MT Newswires

Pre-Market Most Active for Jun 11, 2014 : ING, MTU, BAC, ACHN, OREX, MU, LYG, FB, OSUR, AAPL, NVO, TWTR
6/11/2014 8:39:53 AM - NASDAQ.com News

Orexigen Investors Hope For FDA Approval
6/10/2014 1:22:00 PM - Seeking Alpha

Orexigen Could Be A Double-Edged Sword For Arena
6/9/2014 5:22:00 PM - Seeking Alpha